Here are Monday's biggest calls on Wall Street: JPMorgan initiates Wise as overweight JPMorgan said the money transfer company has plenty of upside. "We expect that Wise will be delivering net revenue growth above the mid-term guidance range in Q1 and Q2, with clear positive momentum in volumes, user activity and balances." Goldman reiterates Advanced Micro Devices as buy The firm raised its price target on the stock o $640 per share from $450. " AMD (Buy) - We see upside in the quarter driven mainly by server CPUs, with some level of potential offset in terms of PC downside; we see a favorable setup for the stock driven by strength in Server CPUs. Goldman Sachs reiterates Sandisk as buy The firm raised its price target on Sandisk to $2,200 per share from $1,200. "We believe investor expectations are very elevated into the print given extremely strong 2Q guidance, as well as positive commentary from management in recent weeks." Goldman Sachs initiates Forbright as buy Goldman said the middle market bank is well positioned. "We initiate coverage of Forbright Inc (FRBT), a digital deposit led middle-market bank, with a Buy Rating and a $23.50 price target (~25% upside)." Bank of America reiterates IBM as buy The firm raised its price target on the stock to $330 per share from $315. "Reit. Buy as IBM i s mixing up to higher margin software (incl. M & A), driving strong FCF, & optionality from quantum." HSBC downgrades Allstate to hold from buy The firm said it sees little upside for Allstate shares. "P & C insurance stocks have been a beneficiary of the sector rotation trade that is currently underway in the US markets. With risk-adjusted rates either stable or declining, we see little change in industry dynamics that could push the stocks meaningfully higher from here on." Goldman Sachs reiterates Netflix as buy Goldman lowered its price target to $110 per share from $120 but says it's sticking with Netflix. "In terms of industry data, we frame the upcoming earnings report as likely to demonstrate a headwind to user growth (not reported) and engagement from a mixture of headwinds (seasonality, content slate & being further removed from live event impact)." TD Cowen upgrades Flagstar to buy from hold TD Cowen said it sees EPS inflections ahead. "We upgrad e FLG to Buy as improving visibility into earnings acceleration and sustained profitability gains strengthen our confidence in the turnaround, while rent-regulated multifamily risk appears manageable." Jefferies upgrades US Bancorp to buy from hold Jefferies says trends are inflecting "favorably." "We're upgradin g U.S. Bancorp to BUY from HOLD as trends inflect more favorably with updates at a recent conference pointing to NII [net interest income] and fee income trending toward the high end of the 6-7% guides for each." Wolfe reiterates Microsoft as outperform Wolfe lowered its price target on the stock but says it's sticking with Microsoft. "Recent memory price increases have led us to raise our MSFT FY27 Capex estimates ($270B vs. $230B prior), and correspondingly decrease FY27 profitability estimates, as we now estimate MSFT having negative FCF in FY27. Reiterate OP and decrease PT to $525 (vs. $570 prior)." Citi adds a positive catalyst watch on Micron Citi said it sees higher pricing for Micron. "We add upside Catalyst Watch on MU on higher 2H26 DRAM prices..." Bernstein reiterates Nvidia as outperform Bernstein said it's sticking with Nvidia. "The datacenter opportunity is enormous, and still early, with material upside still possible. Morgan Stanley initiates ERock as overweight The firm said the power platform company has a "differentiated" offering. "ERock i s a power platform provider with a ~$1.3B backlog supporting a > 80% revenue CAGR (2025-2030)." Bank of America initiates Parabilis Medicines as buy The firm said the biotech company has a differentiated offering. "We initiate coverage o f Parabilis Medicines ( PBLS) with a Buy and $45 PO." Bank of America upgrades T-Mobile to buy from neutral Bank of America said shares are undervalued. "We upgrade T-Mobile to Buy from Neutral with an unchanged $220 price objective." Stifel initiates WhiteHawk Minerals as buy Stifel said the nat gas royalty company is firing on all cylinders. "We are initiating coverage of WhiteHawk Minerals Corp. (WHK) with a Buy rating and $30 target price." Jefferies upgrades Agnico Eagle Mines Limited to buy from hold Jefferies upgraded the metals and mining stock mainly on valuation. "Given the sharp selloff in gold equities, with gold down ~3% ytd and the GDX down ~9%, there are many high quality companies trading at attractive levels, in our view. As such, we upgrade AEM from Hold to Buy, based on valuation." Wells Fargo reiterates First Solar as overweight Wells raised its price target to $320 per share from $255. "We're updating our FSLR m odel to reflect potential upside from a Section 232 polysilicon tariff decision that could be announced by early August. We now model US bookings for 2028+ at $0.42/W, increasing our PT to $320/sh from $255/sh. We remain OW." Read more. Baird downgrades Citizens and M & T Bank to neutral from outperform and Regions to underperform from neutral Baird downgraded several banks on Monday and says the risk/reward is negative. "Bank group near fair value following recent move - downgrading RF to Underperform, CFG/ MTB to Neutral. From our perspective, the risk/reward trade-off is neutral to negatively skewed at current prices, as banks are nearing a cyclical peak in ROEs and valuations aren't especially attractive." Raymond James downgrades Delta to outperform from strong buy and JetBlue to underperform from market perform The firm said in its downgrade of Delta t hat it sees slightly less upside. The firm also said it sees Chapter 11 as the best course of action for JetBlue. "However, following the recent run-up in shares, somewhat narrower near-term upside valuation prompts our rating change from Strong Buy to Outperform. ... . JetBlue shares are further constrained by ~$6.12 conversion price of its convertible debt..." HBSC upgrades Gilead to buy from hold HSBC said investors should buy the dip. "Gilead – upgrade to Buy (from Hold): The market is too pessimistic on the HIV market post-dolutegravir generics, in our view. We believe the long-acting HIV therapies will improve adherence and help offset declines, supporting better-than-consensus HIV forecasts." Morgan Stanley downgrades Truist and Prosperity Bancshares to equal weight from overweight Morgan Stanley downgrades Prosperity and Truist citing deposit competition. "Deposit competition is likely to accelerate given a mix of cyclical and secular factors, gaining investor attention in 2H." Barclays upgrades Lincoln National to overweight from equal weight Barclays said it sees a slew of positive catalysts ahead for the insurance company. "We are upgrading LNC to Overweight (from Equal Weight), supported by four key factors: our view that the company is nearing the end of its capital-building process and may soon be able to redeploy capital through share repurchases..." Bernstein downgrades Datadog to market perform from outperform Bernstein said it sees slowing demand for Datadog. "DOWNGRADE on Q3+ earnings caution vs. more exuberant investor expectations: demand signals slowing in both enterprise and some AI Labs."
<small>Source: CNBC</small>
